ALS Disease

Amyotrophic lateral sclerosis (ALS) is a late-onset fatal neurodegenerative disease affecting motor neurons with an incidence of about 1/100,000. Most ALS cases are sporadic, but 5–10% of the cases are familial ALS. Both sporadic (SALS) and familial ALS (FALS) are associated with degeneration of cortical and spinal motor neurons.(1) The causes of amyotrophic lateral sclerosis are only partly known, but they include some environmental risk factors as well as several genes that have been identified as harbouring disease-associated variation.(2) Genetic studies have implicated deficits in autophagy and/or mitophagy in the onset of the disease.(3) So far, there is no breakthrough for the treatment of ALS. The main treatments are neuroprotective treatment, symptomatic and supportive treatment as well as some unproven disease-modifying therapies such as stem cell transplantation and gene therapy.(4)

Recombinant monoclonal antibodies for ALS disease research

We support your ALS research with reliable, recombinant monoclonal antibodies with high batch-to-batch consistency. Below you will find some of our most referenced or bestselling products.

Produit Reactivity Clonalité Application N° du produit Quantité Relevance ProductGrid: uniqueid
anti-Amyotrophic Lateral Sclerosis 2 (Juvenile) (ALS2) (AA 221-321) anticorps Human, Mouse (Murine) Monoclonal WB ABIN790754 100 μg element-ABIN790754
anti-C9ORF72 anticorps (Chromosome 9 Open Reading Frame 72) Human Monoclonal WB ABIN5563055 100 μL element-ABIN5563055
anti-FUS anticorps Human Monoclonal IF, IHC (p), WB ABIN5649964 100 μL element-ABIN5649964
anti-Superoxide Dismutase 1, Soluble (SOD1) anticorps Human, Mouse (Murine) Monoclonal ICC, FACS, ELISA, WB ABIN969412 100 μL element-ABIN969412
anti-TANK-Binding Kinase 1 (TBK1) anticorps Cow (Bovine) Monoclonal WB ABIN531955 100 μg element-ABIN531955
anti-TAR DNA Binding Protein (TARDBP) (AA 1-260) anticorps Human Monoclonal IF, IHC (p), IP, RNAi, ELISA, WB ABIN565080 100 μg element-ABIN565080
anti-Ubiquilin 2 (UBQLN2) (AA 555-624) anticorps Human Monoclonal IF, ELISA, WB ABIN565449 100 μg element-ABIN565449
anti-Valosin Containing Protein (vcp) anticorps Human, Mouse (Murine) Monoclonal ICC, FACS, WB ABIN302102 0.1 mg element-ABIN302102

References

(1) Zarei S, Carr K, Reiley L, Diaz K, Guerra O, Altamirano PF, Pagani W, Lodin D, Orozco G, Chinea A. A comprehensive review of amyotrophic lateral sclerosis. Surg Neurol Int. 2015 Nov 16;6:171. doi: 10.4103/2152-7806.169561. PMID: 26629397; PMCID: PMC4653353.

(2) Martin S, Al Khleifat A, Al-Chalabi A. What causes amyotrophic lateral sclerosis? F1000Res. 2017 Mar 28;6:371. doi: 10.12688/f1000research.10476.1. PMID: 28408982; PMCID: PMC5373425.

(3) Evans, C.S., Holzbaur, E.L.F. Autophagy and mitophagy in ALS. Neurobiol. Dis. 122, 35–40 (2019).

(4) Tao QQ, Wu ZY. Amyotrophic Lateral Sclerosis: Precise Diagnosis and Individualized Treatment. Chin Med J (Engl). 2017 Oct 5;130(19):2269-2272. doi: 10.4103/0366-6999.215323. PMID: 28937029; PMCID: PMC5634073.